BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34089275)

  • 1. Clinical Utility of
    Li L; Liu FT; Li M; Lu JY; Sun YM; Liang X; Bao W; Chen QS; Li XY; Zhou XY; Guan Y; Wu JJ; Yen TC; Jang MK; Luo JF; Wang J; Zuo C;
    Mov Disord; 2021 Oct; 36(10):2314-2323. PubMed ID: 34089275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
    Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O
    JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
    Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
    Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hsu JL; Chen SH; Hsiao IT; Lu CS; Yen TC; Okamura N; Lin KJ; Weng YH
    Sci Rep; 2020 Nov; 10(1):19410. PubMed ID: 33173080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy.
    Ma JH; Dong C; Qiao HW; Barret O; Tamagnan GD; Mao W; Xu EH; Zhang C; Lu J; Chan P; Liu SY
    Mov Disord; 2024 May; 39(5):847-854. PubMed ID: 38477228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased basal ganglia binding of
    Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
    Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
    Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
    Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
    Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of [
    Oliveira Hauer K; Pawlik D; Leuzy A; Janelidze S; Hall S; Hansson O; Smith R
    Parkinsonism Relat Disord; 2023 Jan; 106():105226. PubMed ID: 36442367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau imaging with [
    Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
    Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis.
    Jin J; Su D; Zhang J; Li X; Feng T
    J Neurol; 2023 May; 270(5):2451-2467. PubMed ID: 36633672
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu FT; Lu JY; Li XY; Liang XN; Jiao FY; Ge JJ; Wu P; Li G; Shen B; Wu B; Sun YM; Zhu YH; Luo JF; Yen TC; Wu JJ; Zuo CT; Wang J;
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1395-1405. PubMed ID: 36627498
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Messerschmidt K; Barthel H; Brendel M; Scherlach C; Hoffmann KT; Rauchmann BS; Rullmann M; Marek K; Villemagne VL; Rumpf JJ; Saur D; Schroeter ML; Schildan A; Patt M; Beyer L; Song M; Palleis C; Katzdobler S; Fietzek UM; Respondek G; Scheifele M; Nitschmann A; Zach C; Barret O; Madonia J; Russell D; Stephens AW; Koglin N; Roeber S; Herms J; Bötzel K; Bartenstein P; Levin J; Seibyl JP; Höglinger G; Classen J; Sabri O;
    J Nucl Med; 2022 Nov; 63(11):1754-1760. PubMed ID: 35422444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison between
    Satoh R; Ali F; Botha H; Lowe VJ; Josephs KA; Whitwell JL
    Neuroimage; 2024 Feb; 286():120509. PubMed ID: 38184157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins.
    Perez-Soriano A; Arena JE; Dinelle K; Miao Q; McKenzie J; Neilson N; Puschmann A; Schaffer P; Shinotoh H; Smith-Forrester J; Shahinfard E; Vafai N; Wile D; Wszolek Z; Higuchi M; Sossi V; Stoessl AJ
    Mov Disord; 2017 Jul; 32(7):1016-1024. PubMed ID: 28568506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo binding of a tau imaging probe, [
    Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M
    Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.